Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients

NCT05743504 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Tiragolumab

Sponsor

National Taiwan University Hospital